PROIBS

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Eli Lilly’s retatrutide moves closer to a planned 2027 U.S. filing after completing its core Phase 3 programme for obesity, knee pain and sleep apnea. Representative image.

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

India and Canada are accelerating CEPA negotiations as LNG, nuclear energy and critical minerals become central to their expanding economic relationship. Representative image.

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

The White House press-access dispute intensified after MS NOW journalists said their credentials were disabled following Donald Trump’s media ban. Representative image.

Trump White House media ban takes effect as MS NOW journalists are turned away

Smoke near Riyadh’s King Khalid International Airport followed Saudi aerial danger alerts as the conflict with Yemen’s Houthis intensifies. Representative image.

Smoke rises near Riyadh airport after Saudi aerial alerts as Houthi conflict escalates

Immuron (ASX: IMC) takes PROIBS to US as Nasdaq ADR jumps 62%

Immuron Limited has signed an exclusive U.S. distribution agreement with Sweden’s Calmino group AB for PROIBS, extending its digestive-health portfolio beyond Travelan after reporting record FY26 sales of A$7.7 million.

bySrinath

September 6, 2026

Is Immuron (ASX: IMC) quietly staging a turnaround? PROIBS launch sparks 20% rally

Immuron (ASX: IMC) shares jumped 20 percent following its IBS product launch. Can the PROIBS rollout turn this microcap into a digestive health contender?

byVenkatesh

October 26, 2025

The Latest

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

Trump White House media ban takes effect as MS NOW journalists are turned away

Smoke rises near Riyadh airport after Saudi aerial alerts as Houthi conflict escalates

Immuron (ASX: IMC) takes PROIBS to US as Nasdaq ADR jumps 62%

Is Immuron (ASX: IMC) quietly staging a turnaround? PROIBS launch sparks 20% rally

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

Trump White House media ban takes effect as MS NOW journalists are turned away

Smoke rises near Riyadh airport after Saudi aerial alerts as Houthi conflict escalates

India and Pakistan trade accusations after INS Kolkata collides with PNS Hunain

Kohat police mosque attack death toll reaches 31 after 20-hour security operation

Autonomous construction equipment: How AI is moving heavy machinery out of the cab

TikTok’s $400m US privacy settlement hits judicial hurdle over 2019 consent decree